Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

IMI

This page shows the latest IMI news and features for those working in and with pharma, biotech and healthcare.

Almirall set to participate in Innovative Medicines Initiative’s FACILITATE project

Almirall set to participate in Innovative Medicines Initiative’s FACILITATE project

The project, which received approval from the IMI Joint Undertaking (European Commission and EFPIA) in 2021, has been initiated this year in tandem with the FACILITATE website. ... At Almirall, we are excited to contribute to this patient-driven IMI

Latest news

More from news
Approximately 14 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Exploiting the value of data in pharma Exploiting the value of data in pharma

    Accelerate development. Again, in March, the Innovative Medicines Initiative (IMI) issued a call for Innovation Actions into detections, therapeutics, antivirals and diagnostics (not vaccines).

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    EPAD is co-funded by the Innovative Medicines Initiative (IMI) and Europe’s pharma industry organisation EFPIA, and 2019 will see the first patients being treated by this groundbreaking new alliance. ... Funding for EPAD from IMI comes to an end in

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • A quest for innovative solutions A quest for innovative solutions

    The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a barometer of the industry’s deep dive into technology at a time when ageing populations with multiple

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    There are a number of collaborations we have with biotech companies in Europe, but regarding the IMI collaboration, it is too early yet for discussion.”. ... Several other companies are signed up to the IMI's efforts in AMR, including GlaxoSmithKline,

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Innovative Medicines Initiative appoints executive director Innovative Medicines Initiative appoints executive director

    Pierre Meulien joins from Genome Canada . Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”.

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    Its second-phase IMI 2 programme aims to develop next generation vaccines, medicines and treatments, such as new antibiotics. ... I am confident that his decades of experience working in the pharmaceutical sector will prove invaluable to IMI.”.

  • IMI appoints new chair of scientific committee IMI appoints new chair of scientific committee

    Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI). ... Finally, there is huge potential to expand the principles underlying IMI to the rest of the world.”.

  • Hans Lennernas joins board of CMO Recipharm Hans Lennernas joins board of CMO Recipharm

    Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......

Quick links